Logo.png
Vyant Bio to Present at the Q4 Investor Summit Micro & Small Cap Conference
10 nov. 2021 16h15 HE | Vyant Bio, Inc.
Cherry Hill, N.J., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
Logo.png
Vyant Bio Announces Investor Conference Call and Webcast for Second Quarter 2021
11 août 2021 09h00 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
CocrystalPharmaInc.jpg
Cocrystal Pharma Announces Filing 2017 Third Quarter Financial Statements and Provides Company Update
08 nov. 2017 17h30 HE | Cocrystal Pharma, Inc.
ATLANTA, GA and BOTHELL, WA, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, today announced...